PMC:7205724 / 1410-1626
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
51 | 100-103 | Gene | denotes | IL6 | Gene:3569 |
52 | 157-160 | Gene | denotes | IL6 | Gene:3569 |
60 | 33-41 | Species | denotes | patients | Tax:9606 |
61 | 138-146 | Species | denotes | patients | Tax:9606 |
62 | 201-210 | Species | denotes | SARS-CoV2 | Tax:2697049 |
64 | 57-68 | Chemical | denotes | Tocilizumab | MESH:C502936 |
76 | 47-55 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T5 | 83-91 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T6 | 211-215 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T17 | 47-55 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T18 | 201-205 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 70-71 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 211-215 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-sample-MedDRA
Id | Subject | Object | Predicate | Lexical cue | meddra_id |
---|---|---|---|---|---|
T3 | 4-14 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | viral load | http://purl.bioontology.org/ontology/MEDDRA/10062178 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 211-215 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T17 | 47-55 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T18 | 201-210 | Species | denotes | SARS-CoV2 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19 | 57-168 | Sentence | denotes | Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
60 | 33-41 | Species | denotes | patients | Tax:9606 |
76 | 47-55 | Disease | denotes | COVID-19 | MESH:C000657245 |
64 | 57-68 | Chemical | denotes | Tocilizumab | MESH:C502936 |
51 | 100-103 | Gene | denotes | IL6 | Gene:3569 |
61 | 138-146 | Species | denotes | patients | Tax:9606 |
52 | 157-160 | Gene | denotes | IL6 | Gene:3569 |
62 | 201-210 | Species | denotes | SARS-CoV2 | Tax:2697049 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T177 | 100-103 | Protein | denotes | IL6 | https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0 |
T221 | 157-160 | Protein | denotes | IL6 | https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0 |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T212 | 2-3 | -COMMA- | denotes | , |
T213 | 4-9 | JJ | denotes | viral |
T214 | 10-14 | NN | denotes | load |
T215 | 14-15 | -COMMA- | denotes | , |
T216 | 16-19 | CC | denotes | and |
T217 | 20-29 | NN | denotes | prognosis |
T218 | 30-32 | IN | denotes | of |
T219 | 33-41 | NNS | denotes | patients |
T220 | 42-46 | IN | denotes | with |
T221 | 47-55 | NN | denotes | COVID-19 |
T222 | 57-68 | NNP | denotes | Tocilizumab |
T223 | 68-69 | -COMMA- | denotes | , |
T224 | 70-71 | DT | denotes | a |
T225 | 72-82 | JJ | denotes | monoclonal |
T226 | 83-91 | NN | denotes | antibody |
T227 | 92-99 | IN | denotes | against |
T228 | 100-103 | NN | denotes | IL6 |
T229 | 103-104 | -COMMA- | denotes | , |
T230 | 105-110 | MD | denotes | could |
T231 | 111-117 | VB | denotes | confer |
T232 | 118-126 | JJ | denotes | clinical |
T233 | 127-134 | NN | denotes | benefit |
T234 | 135-137 | IN | denotes | in |
T235 | 138-146 | NNS | denotes | patients |
T236 | 147-151 | IN | denotes | with |
T237 | 152-156 | JJ | denotes | high |
T238 | 157-160 | NN | denotes | IL6 |
T239 | 161-167 | NNS | denotes | levels |
T240 | 169-178 | JJ | denotes | Essential |
T241 | 179-187 | NNS | denotes | elements |
T242 | 188-192 | IN | denotes | that |
T243 | 193-200 | NN | denotes | process |
T244 | 201-210 | NN | denotes | SARS-CoV2 |
T245 | 211-215 | NN | denotes | cell |
R204 | T214 | T212 | arg2Of | load,"," |
R205 | T214 | T213 | arg1Of | load,viral |
R206 | T216 | T215 | arg1Of | and,"," |
R207 | T212 | T216 | arg1Of | ",",and |
R208 | T217 | T216 | arg2Of | prognosis,and |
R209 | T217 | T218 | arg1Of | prognosis,of |
R210 | T219 | T218 | arg2Of | patients,of |
R211 | T219 | T220 | arg1Of | patients,with |
R212 | T221 | T220 | arg2Of | COVID-19,with |
R213 | T222 | T223 | arg1Of | Tocilizumab,"," |
R214 | T226 | T223 | arg2Of | antibody,"," |
R215 | T226 | T224 | arg1Of | antibody,a |
R216 | T226 | T225 | arg1Of | antibody,monoclonal |
R217 | T226 | T227 | arg1Of | antibody,against |
R218 | T228 | T227 | arg2Of | IL6,against |
R219 | T231 | T229 | arg1Of | confer,"," |
R220 | T222 | T230 | arg1Of | Tocilizumab,could |
R221 | T231 | T230 | arg2Of | confer,could |
R222 | T222 | T231 | arg1Of | Tocilizumab,confer |
R223 | T233 | T231 | arg2Of | benefit,confer |
R224 | T233 | T232 | arg1Of | benefit,clinical |
R225 | T231 | T234 | arg1Of | confer,in |
R226 | T235 | T234 | arg2Of | patients,in |
R227 | T235 | T236 | arg1Of | patients,with |
R228 | T239 | T236 | arg2Of | levels,with |
R229 | T239 | T237 | arg1Of | levels,high |
R230 | T239 | T238 | arg1Of | levels,IL6 |
R231 | T241 | T240 | arg1Of | elements,Essential |
R232 | T241 | T242 | arg1Of | elements,that |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T5 | 83-91 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T6 | 211-215 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T17 | 47-55 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T18 | 201-210 | Disease | denotes | SARS-CoV2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19 | 57-168 | Sentence | denotes | Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels. |